Cyberonics vets “equity ownership” initiative
This article was originally published in The Gray Sheet
Executive Summary
With the impending approval of VNS Therapy for depression, the Houston-based firm plans to hire 200 additional employees (1"The Gray Sheet" Feb. 7, 2005, p. 3). As part of the compensation plan for the new hires, Cyberonics wants to issue 1 mil. shares of restricted stock or options to purchase common stock at fair market value to qualified employees and board members. Shareholders will vote on the plan during a May 19 meeting...
You may also be interested in...
Cyberonics Depression Approval Contingent On Dosing Trial, Registry
Cyberonics will start a 450-patient, three-year dosing trial in order to gain PMA approval for its VNS Therapy neuromodulation device for use in treatment-resistant depression patients
Philips Portfolio Includes ‘No Single Product That Does Not Use A Type Of AI,’ Says CEO And AI Thought Leader Roy Jakobs
Philips CEO Roy Jakobs talks to Medtech Insight about the medtech firm’s decade-long history of embedding AI into its products and what he expects from the newly released draft framework by the National Academy of Medicine, which he helped develop as co-chair of the Steering Committee.
MoCRA Stakeholders Reminded Registration Enforcement Begins 1 July: ‘Do Not Delay!’
The Independent Beauty Association urged stakeholders at its Cosmetic Convergence Symposium to take action to ensure they are meeting requirements of the Modernization of Cosmetics Regulation Act come 1 July, when FDA’s enforcement of the facility and product registration deadline begins. Presenters offered tips from companies that have already completed the process.